Summary of Key Points Core Viewpoint - The recent announcement by Xin'ao Co., Ltd. regarding the repurchase and cancellation of restricted stock under its 2023 incentive plan has attracted market attention, raising questions about the reasons behind this decision and its potential impact on the company. Group 1: Reasons for Repurchase and Cancellation - The repurchase and cancellation of restricted stock is due to the failure of certain incentive recipients to meet personal performance assessments or their retirement or departure from the company without meeting the conditions for lifting restrictions. A total of 193,500 shares will be repurchased from 8 individuals [1]. - After the repurchase, the remaining restricted stock under the incentive plan will amount to 9,638,700 shares [1]. Group 2: Repurchase Arrangement - The company has opened a dedicated repurchase securities account with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, and has submitted the necessary application for the repurchase and cancellation [2]. - The completion of the repurchase is expected by September 5, 2025, after which the company will proceed with the required business registration changes [2]. Group 3: Compliance with Procedures - On June 17, 2025, the company held its 20th meeting of the sixth board of directors, where it approved the proposal to adjust the repurchase price and cancel part of the restricted stock. This proposal was reviewed and approved by the Compensation and Assessment Committee [3]. - A temporary shareholders' meeting was convened on July 4, 2025, to review and approve related proposals [3]. Group 4: Information Disclosure - The company disclosed relevant resolutions and announcements on June 18 and July 5, 2025, ensuring compliance with information disclosure obligations [4]. - As of the date of the legal opinion, the disclosure period has been completed for 45 days, during which no creditors have requested early debt repayment or guarantees [4]. - The legal firm Guohao (Hangzhou) believes that the repurchase and cancellation comply with relevant laws and regulations, and the necessary procedures and information disclosures have been fulfilled [4].

Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Firm confirms that Tongling Jieya Biotechnology Co., Ltd. has complied with relevant laws and regulations regarding its 2025 Restricted Stock Incentive Plan, including necessary approvals and authorizations for the initial grant of restricted stock [1][3][4]. Summary by Sections Approval and Authorization of Grant - The Compensation and Assessment Committee and the Board of Directors have approved the draft of the 2025 Restricted Stock Incentive Plan and related proposals [3][4]. - The company has fulfilled necessary approval and authorization procedures for the grant of restricted stock [4][5]. Basic Information of the Grant - The initial grant date for the restricted stock is set for September 2, 2025, with a total of 1,498,000 shares to be granted to 10 incentive recipients [4][5]. - The grant date complies with the regulations, being within 60 days of the shareholders' meeting approval [5]. Recipients of the Grant - The distribution of the granted shares among the recipients is as follows: - Directors and senior management will receive 38.46% of the total shares, while other incentivized personnel will receive 43.85% [6]. - The total number of shares granted to the 10 recipients is 1,498,000, with a reserved portion of 322,000 shares [6]. Conditions for Granting - Recipients must meet specific conditions to be eligible for the restricted stock, including no negative audit opinions in the last fiscal year and no legal restrictions on participating in stock incentives [7][8]. - The company has confirmed that all conditions for granting the restricted stock have been met [8]. Conclusion - The legal opinion concludes that all necessary approvals, grant dates, recipient qualifications, and conditions have been satisfied, ensuring compliance with the relevant regulations [8].

Core Viewpoint - The company has approved the first grant of restricted stock under its 2025 Restricted Stock Incentive Plan, granting 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible recipients, with the grant date set for September 2, 2025 [1][10][14]. Summary by Sections Incentive Plan Overview - The 2025 Restricted Stock Incentive Plan aims to motivate directors, senior management, and other key personnel deemed necessary for incentivization [1][4]. - The total number of shares granted is 1,498,000, which represents 82.31% of the total incentive plan [3][11]. Grant Details - The grant includes 1,498,000 shares to 10 recipients, with 700,000 shares allocated to directors and senior management, and 798,000 shares to other incentivized personnel [3][11]. - A reserve of 322,000 shares (17.69% of the total) is set aside for future grants [3][11]. Vesting Conditions - The vesting of the restricted stock is contingent upon meeting specific performance targets over three years, with annual assessments [6][7]. - The performance targets are set as follows: - 2025: Revenue growth of at least 25% compared to 2024 - 2026: Revenue growth of at least 50% compared to 2024 - 2027: Revenue growth of at least 100% compared to 2024 [6][7]. Approval Process - The plan has undergone necessary approvals, including reviews by the Compensation and Assessment Committee and the Board of Directors [9][10]. - The company has confirmed that all grant conditions have been met, ensuring compliance with relevant regulations [10][14]. Financial Impact - The fair value of the restricted stock will be calculated using the Black-Scholes model, and the associated costs will be recognized over the vesting period [11][12]. - The estimated total expense for the first grant will impact the company's net profit across the years 2025 to 2028 [12]. Compliance and Legal Review - A legal opinion confirms that the grant complies with all applicable laws and regulations, and the eligibility of the recipients has been verified [14][15].

Group 1 - The incentive plan involves the allocation of restricted stocks among various incentive recipients, with a total of 182,000 shares granted, representing 1.62% of the company's total share capital [1] - The distribution of granted rights includes 70,000 shares (38.46%) for directors and senior management, and 79,800 shares (43.85%) for other personnel deemed necessary for motivation [1] - A reserved portion of 32,200 shares (17.69%) is also included in the incentive plan, bringing the total granted rights to 182,000 shares [1] Group 2 - The company will disclose relevant information about the incentive recipients in a timely and accurate manner after receiving clear opinions from the Compensation and Assessment Committee and legal counsel [2] - The list of other personnel deemed necessary for motivation by the board of directors is also mentioned, indicating a structured approach to employee incentives [2]

证券代码：301338 证券简称：凯格精机 公告编号：2025-032 股份有限公司 2025 年限制性股票激励计划激励对象名单公示》，对公司本次激 励对象名单予以公示，公示时间为 2025 年 8 月 15 日至 2025 年 8 月 24 日。 截止公示期满，公司董事会薪酬与考核委员会与监事会未收到任何人对本次 激励计划激励对象提出的异议。 董事会薪酬与考核委员会与监事会 关于公司 2025 年限制性股票激励计划激励对象名单 公示情况说明及核查意见 本公司及董事会薪酬与考核委员会、监事会全体成员保证信息披露的内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 东莞市凯格精机股份有限公司（以下简称"公司"）于 2025 年 8 月 15 日召 开第二届董事会第十六次会议、第二届监事会第十五次会议审议通过了《关于< 东莞市凯格精机股份有限公司 2025 年限制性股票激励计划（草案）>及其摘要的 议案》等相关议案。具体内容详见公司于 2025 年 8 月 15 日在巨潮资讯网 （www.cninfo.com.cn）上披露的相关公告。 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 ...

Group 1 - The board of directors of Tongling Jieya Biotechnology Co., Ltd. held its fourth meeting of the sixth session on September 2, 2025, via communication, with all members ensuring the accuracy and completeness of the disclosed information [1] - The board approved the first grant of the 2025 restricted stock incentive plan, agreeing to grant 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible incentive objects, with the grant date set for September 2, 2025 [2] - The voting results for the resolution were 4 votes in favor, 0 against, and 0 abstentions, with certain directors recusing themselves from the vote due to conflicts of interest [2]

Group 1 - The company has reviewed the list of incentive recipients for the 2025 restricted stock incentive plan and confirmed that all recipients meet the necessary legal and regulatory conditions [1][2] - The incentive recipients do not include independent directors, foreign employees, or shareholders holding 5% or more of the company's shares [2] - The first grant date for the incentive plan is set for September 2, 2025, with a total of 10 recipients receiving restricted stock [2]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss important matters including changes to the registered capital and amendments to the Articles of Association [1][6] - The meeting will take place on September 12, 2025, at 14:00, with both on-site and online voting options available for shareholders [3][2] Meeting Procedures - The meeting will be organized by a dedicated working group to ensure order and efficiency [1] - Only authorized shareholders, board members, and invited personnel are allowed to attend, while other individuals may be refused entry [2] - Shareholders wishing to speak must register in advance and adhere to a three-minute time limit for their remarks [2][5] - Voting will be conducted through a combination of on-site and online methods, with specific details provided in the meeting notice [2][3] Agenda Items - The primary agenda item is the proposal to change the company's registered capital and amend the Articles of Association due to the repurchase and cancellation of part of the restricted stock incentive plan [8] - The total number of shares will decrease from 262,633,500 to 262,496,300, resulting in a reduction of registered capital from RMB 262,633,500 to RMB 262,496,300 [8][6] - The company seeks authorization from the shareholders to allow the board or management to handle the necessary business registration changes [8]

Core Viewpoint - The company has completed the repurchase and cancellation of 103,994 restricted stocks, which accounts for 0.02% of the total share capital before the repurchase, due to the departure of certain incentive targets [2][8]. Group 1: Repurchase and Cancellation Details - The repurchase price for the restricted stocks is set at 4.458 yuan per share, with a total cost of 46.36 thousand yuan, funded by the company's own resources [2][12]. - Following the cancellation, the company's total share capital will decrease from 504,968,262 shares to 504,864,268 shares [2][12]. - The repurchase was approved during the company's board and supervisory meetings held on April 25, 2025, and subsequently ratified by the shareholders [3][8]. Group 2: Background of the Incentive Plan - The 2022 restricted stock incentive plan was initially approved by the board on December 30, 2022, and received the necessary regulatory approvals [4][5]. - The plan included provisions for the repurchase of stocks in cases where incentive targets left the company due to uncontrollable circumstances [9][10]. Group 3: Financial Adjustments and Impact - The repurchase price was adjusted due to previous cash distributions, resulting in a final repurchase price of 4.458 yuan per share [11][12]. - The cancellation of these stocks is not expected to impact the company's operational performance or management responsibilities [14].

Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan and has publicly disclosed the list of initial grant recipients, ensuring compliance with relevant regulations and internal governance [1][2][4]. Group 1: Incentive Plan Approval - The company held the seventh meeting of the sixth board of directors on August 21, 2025, where the 2025 Restricted Stock Incentive Plan draft and its summary were approved [1]. - The plan includes the establishment of an assessment management method for its implementation [1]. Group 2: Public Disclosure and Feedback - The list of initial grant recipients was published on the company's official website on August 22, 2025, with a public feedback period from August 22 to August 31, 2025 [2]. - No objections were raised by employees during the public feedback period [2]. Group 3: Verification Process - The Compensation and Assessment Committee verified the eligibility of the proposed recipients, including their employment contracts and positions within the company [3][4]. - The verification confirmed that all proposed recipients meet the conditions set forth in relevant laws and regulations [4][7]. Group 4: Eligibility Criteria - The proposed recipients do not fall under any disqualifying conditions as outlined in the management regulations, such as being deemed inappropriate candidates by regulatory authorities within the last 12 months [5][6]. - The recipients include directors, senior management, and core technical personnel, excluding independent directors and major shareholders [6][7]. Group 5: Inclusion of Foreign Employees - The plan includes foreign employees who are considered key technical personnel, which aligns with the company's operational needs and long-term development goals [6][7].